Reduction of reperfusion-induced ventricular fibrillation and infarct size via heme oxygenase-1 overexpression in isolated mouse hearts

被引:13
作者
Bak, Istvan [1 ]
Czompa, Attila [1 ]
Juhasz, Bela [1 ]
Lekli, Istvan [1 ]
Tosaki, Arpad [1 ]
机构
[1] Univ Debrecen, Dept Pharmacol, Hlth Sci Ctr, Fac Pharm, H-4012 Debrecen, Hungary
关键词
ischemia; reperfusion; isolated mouse hearts; HO-1; transgenic; knockout; CARBON-MONOXIDE; MYOCARDIUM; ARRHYTHMIA; GENE;
D O I
10.1111/j.1582-4934.2010.01142.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Heme oxygenase-1 (HO-1), also known as heat shock protein 32 (hsp-32) is a stress-induced cytoprotective protein. The present investigation evaluated the capacity of HO-1 to reduce the incidence of reperfusion-induced ventricular fibrillation (VF) and infarct size. HO-1 transgenic (Tg) mice were generated using a rat HO-1 genomic transgene. Isolated mouse hearts obtained from Tg and non-transgenic (NTg) groups were exposed to 20 min. of global ischemia and 120 min. of reperfusion. Epicardial electrocardiogram was recorded to monitor the incidence of reperfusion-induced VF and at the end of the reperfusion period, detection of HO-1 by immunohistochemistry and measurement of infarct size using the tetrazolium chloride method were carried out. Results shown here provide additional support for cardioprotective effects of HO-1 as demonstrated by the reduced infarct size. Moreover, overexpression of the HO-1 efficiently reduced the incidence of ischemia/reperfusion induced VF in HO-1 Tg mice.
引用
收藏
页码:2268 / 2272
页数:5
相关论文
共 12 条
[1]   Systemic rather than local heme oxygenase-1 overexpression improves cardiac allograft outcomes in a new transgenic mouse [J].
Araujo, JA ;
Meng, LZ ;
Tward, AD ;
Hancock, WW ;
Zhai, Y ;
Lee, A ;
Ishikawa, K ;
Iyer, S ;
Buelow, R ;
Busuttil, RW ;
Shih, DM ;
Lusis, AJ ;
Kupiec-Weglinski, JW .
JOURNAL OF IMMUNOLOGY, 2003, 171 (03) :1572-1580
[2]  
Bach FH, 2002, WIEN KLIN WOCHENSCHR, V114, P1
[3]   Heme oxygenase-1 related carbon monoxide production and ventricular fibrillation in isolated ischemic/reperfused mouse myocardium [J].
Bak, I ;
Szendrei, L ;
Turoczi, T ;
Papp, G ;
Joo, F ;
Das, DK ;
de Leiris, J ;
Der, P ;
Juhasz, B ;
Varga, E ;
Bacskay, I ;
Balla, J ;
Kovacs, P ;
Tosaki, A .
FASEB JOURNAL, 2003, 17 (12) :2133-+
[4]   The role of heme oxygenase-related carbon monoxide and ventricular fibrillation in ischemic/reperfused hearts [J].
Bak, I ;
Papp, G ;
Turoczi, T ;
Varga, E ;
Szendrei, L ;
Vecsernyes, M ;
Joo, F ;
Tosaki, A .
FREE RADICAL BIOLOGY AND MEDICINE, 2002, 33 (05) :639-648
[5]   Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning [J].
Ferdinandy, Peter ;
Schulz, Rainer ;
Baxter, Gary F. .
PHARMACOLOGICAL REVIEWS, 2007, 59 (04) :418-458
[6]   Hemoxygenase-1 in cardiovascular disease [J].
Idriss, Naglaa K. ;
Blann, Andrew D. ;
Lip, Gregory Y. H. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (12) :971-978
[7]   Products of heme oxygenase and their potential therapeutic applications [J].
Kirkby, KA ;
Adin, CA .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2006, 290 (03) :F563-F571
[8]   Heme Oxygenase-1 Regulates Cardiac Mitochondrial Biogenesis via Nrf2-Mediated Transcriptional Control of Nuclear Respiratory Factor-1 [J].
Piantadosi, Claude A. ;
Carraway, Martha Sue ;
Babiker, Abdelwahid ;
Suliman, Hagir B. .
CIRCULATION RESEARCH, 2008, 103 (11) :1232-U60
[9]   Cav1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism [J].
Splawski, I ;
Timothy, KW ;
Sharpe, LM ;
Decher, N ;
Kumar, P ;
Bloise, R ;
Napolitano, C ;
Schwartz, PJ ;
Joseph, RM ;
Condouris, K ;
Tager-Flusberg, H ;
Priori, SG ;
Sanguinetti, MC ;
Keating, MT .
CELL, 2004, 119 (01) :19-31
[10]   Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations [J].
Splawski, I ;
Timothy, KW ;
Decher, N ;
Kumar, P ;
Sachse, FB ;
Beggs, AH ;
Sanguinetti, MC ;
Keating, MT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (23) :8089-8096